{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:13:36Z","timestamp":1785726816102,"version":"3.56.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ancard.2008.05.022","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T08:53:41Z","timestamp":1215161621000},"page":"189-191","source":"Crossref","is-referenced-by-count":1,"title":["Une insuffisance aortique diagnostiqu\u00e9e sous cabergoline"],"prefix":"10.1016","volume":"58","author":[{"given":"F.","family":"Chagu\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Belleville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Boujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2008.05.022_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurguitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2008.05.022_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2008.05.022_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","article-title":"Drugs and valvular heart disease","volume":"356","author":"Roth","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2008.05.022_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00045415-200211000-00005","article-title":"Fibrotic valvular heart disease subsequent to bromocriptine treatment","volume":"10","author":"Serratrice","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ancard.2008.05.022_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0035-3787(05)85103-3","article-title":"Valvulopathie sous pergolide\u00a0: revue critique de la litt\u00e9rature et conduite \u00e0 tenir en pratique","volume":"161","author":"Corvol","year":"2005","journal-title":"Rev Neurol"},{"key":"10.1016\/j.ancard.2008.05.022_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","article-title":"Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease","volume":"363","author":"Van Camp","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2008.05.022_bib7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/01.wnl.0000238508.68593.1d","article-title":"Dopamine agonists and cardiac valvulopathy in Parkinson disease","volume":"67","author":"Yamamoto","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ancard.2008.05.022_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mds.21225","article-title":"Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study","volume":"22","author":"Junghanns","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.ancard.2008.05.022_bib9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4065\/80.8.1016","article-title":"Valvular heart disease in patients taking pergolide","volume":"80","author":"Waller","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ancard.2008.05.022_bib10","first-page":"21","article-title":"Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine","volume":"100","author":"Shivelly","year":"1999","journal-title":"Circulation"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392808000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392808000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T12:29:57Z","timestamp":1545913797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392808000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0003392808000851"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2008.05.022","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}